Octagon Capital Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-520,800	Closed	-$1.71M	–	46
2024 Q2	$1.71M	Hold	520,800	–	–	0.27%	38
2024 Q1	$3.82M	Buy	+520,800	New	+$3.82M	0.46%	40
2022 Q4	–	Sell	-331,096	Closed	-$7.42M	–	39
2022 Q3	$7.42M	Buy	+331,096	New	+$7.42M	1.28%	20